The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Functional Annotation Report: Heterocephalus glaber Mb21d1 / cGAS

Executive conclusion

Identity verification passed, with an important evidence limitation. The supplied UniProt record A0AAX6RS70 and RefSeq model XP_021099394.1 identify a predicted Heterocephalus glaber—naked mole-rat—protein named Mb21d1 and described as cyclic GMP–AMP synthase (cGAS) isoform X1. This naming is biologically coherent: mammalian MB21D1, formerly C6orf150, is the gene encoding cGAS, and experimentally characterized cGAS proteins contain the same Mab21/nucleotidyltransferase architecture reported for A0AAX6RS70. No conflicting gene with the same symbol was identified. However, the literature search found no direct biochemical, localization, structural, knockout, or substrate-specificity study of A0AAX6RS70 or XP_021099394.1 itself. The detailed functional annotation below is therefore a high-confidence orthology- and domain-based inference from experimentally characterized mammalian cGAS, not a claim of direct validation in naked mole-rat cells (mann2016structuralandbiochemicala pages 25-28, civril2013structuralmechanismof pages 1-2, mann2016structuralandbiochemicala pages 71-72).

The most defensible primary annotation is:

A DNA-activated cyclic dinucleotide synthase predicted to use ATP and GTP to produce 2′3′-cGAMP, thereby activating STING-dependent innate immune signaling.

Table: This table separates what is directly supported for the supplied naked-mole-rat record from what is inferred from mammalian cGAS literature. It is useful for preventing over-interpretation where direct Heterocephalus glaber functional studies are lacking.

1. Gene and protein identity

• Gene: Mb21d1; standardized functional alias cGAS.
• Protein record: UniProt A0AAX6RS70.
• RefSeq model: XP_021099394.1, “cyclic GMP-AMP synthase isoform X1.”
• Organism: Heterocephalus glaber, the naked mole-rat.
• Annotation status: The “SubName,” “isoform X1,” and ECO:0000313/RefSeq provenance indicate a computationally propagated or predicted protein model rather than a species-specific experimentally reviewed enzyme.

The symbol is not being confused with a different Mab21-family protein. MB21D1/C6orf150 is explicitly identified as cGAS in mammalian structural and biochemical literature, whereas paralogs such as MAB21L1 and MAB21L2 are related developmental proteins and are not interchangeable with MB21D1. The latter can retain the same overall fold while lacking residues needed for canonical cGAS catalysis (civril2013structuralmechanismof pages 1-2, mann2016structuralandbiochemical pages 1-2).

2. Family and structural architecture

The supplied InterPro/Pfam assignments—Mab-21-like nucleotidyltransferase, Mab-21 HhH/H2TH-like, MAB21L/cGLR, PF03281 and PF20266—are consistent with bona fide cGAS architecture. Mammalian cGAS has an N-terminal, relatively disordered basic region followed by a conserved C-terminal catalytic region containing overlapping nucleotidyltransferase (NTase) and Mab21 structural elements. Human cGAS is 522 amino acids long; its conserved C-terminal region contains the catalytic core, DNA-binding surfaces, and zinc-ribbon or “zinc-thumb” element (hertzog2020regulationandinhibition pages 3-4, civril2013structuralmechanismof pages 1-2, tao2017nonspecificdnabinding pages 3-4).

The NTase fold uses conserved acidic residues and divalent metal ions to catalyze nucleotidyl transfer. In the general NTase mechanism, a nucleotide monophosphate is transferred from an NTP donor to an acceptor hydroxyl, releasing pyrophosphate. cGAS performs two sequential transfer reactions to construct a mixed-linkage cyclic dinucleotide (mann2016structuralandbiochemicala pages 25-28, mann2016structuralandbiochemical pages 1-2).

Crystal structures of porcine and human cGAS showed a two-lobed Mab21/NTase catalytic core, a positively charged DNA-binding platform, and a zinc-thumb that recognizes B-form dsDNA. DNA binding drives closure and rearrangement of the lobes and active site, converting the protein from a comparatively inactive state into a catalytically competent enzyme (Civril et al., published May 2013; https://doi.org/10.1038/nature12305) (civril2013structuralmechanismof pages 4-6, civril2013structuralmechanismof pages 1-2).

3. Primary biochemical function

3.1 Catalyzed reaction

For experimentally studied mammalian cGAS, the overall reaction is approximately:

ATP + GTP → 2′3′-cGAMP + 2 PPi, dependent on activating dsDNA and Mg²⁺ or another suitable divalent cation.

The product is cyclic G(2′–5′)pA(3′–5′)p, conventionally called 2′3′-cGAMP. Formation proceeds through two nucleotidyl-transfer steps: cGAS first forms a linear dinucleotide intermediate and subsequently cyclizes it, yielding one 2′–5′ and one 3′–5′ phosphodiester linkage. Biochemical assays with purified human cGAS use ATP and GTP together, MgCl₂, and stimulatory DNA; the resulting cGAMP activates downstream IRF3 signaling (mann2016structuralandbiochemicala pages 71-72, tao2017nonspecificdnabinding pages 3-4, mann2016structuralandbiochemical pages 1-2).

For A0AAX6RS70, this reaction should be treated as strongly predicted, because its annotation and domains match mammalian MB21D1/cGAS, but the naked-mole-rat protein has not been purified and assayed in the retrieved literature.

3.2 Substrate and activator specificity

The nucleotide substrates are ATP and GTP. The physiological allosteric/template-like activator is double-stranded DNA, rather than a particular DNA sequence. cGAS contacts the DNA sugar-phosphate backbone and therefore detects DNA broadly and largely sequence-independently. Relevant DNA can originate from DNA viruses, bacteria, reverse-transcribed retroviral intermediates, damaged nuclei or micronuclei, mitochondria, or endogenous retroelements (hertzog2020regulationandinhibition pages 3-4, dvorkin2024newfrontiersin pages 1-3).

Early structural-biochemical experiments showed activity with 40–50-bp dsDNA and loss of activity when ATP, GTP, or activating dsDNA was omitted; ssDNA was ineffective in those assays. Human cGAS generally responds more efficiently to relatively long DNA, with one review citing a typical requirement of approximately ≥45 bp, whereas mouse cGAS can respond to shorter ligands. DNA length promotes cooperative oligomerization, protein–DNA ladders, and condensate formation, rather than changing sequence specificity (hertzog2020regulationandinhibition pages 3-4, civril2013structuralmechanismof pages 1-2).

These length thresholds should not be assigned numerically to naked-mole-rat cGAS without direct testing. Species-specific substitutions can substantially change cGAS activity, as demonstrated by differences between human and murine enzymes.

4. Molecular activation mechanism

Resting cGAS has a poorly organized or inactive catalytic configuration. Multivalent dsDNA binding brings cGAS molecules together and causes a conformational switch that reorganizes the nucleotide-binding loop and active site. DNA-induced dimerization/oligomerization and, at higher local concentrations, liquid–liquid phase condensation increase cGAMP production. Mutations in the catalytic acidic residues, DNA-binding platform, zinc-thumb, or structural residues stabilizing the nucleotide-binding loop reduce enzymatic and IFN-reporter activity (hertzog2020regulationandinhibition pages 3-4, civril2013structuralmechanismof pages 4-6).

This mechanism explains the supplied domain combination particularly well: the NTase region performs bond formation, while Mab21-family surfaces and the zinc-thumb couple dsDNA recognition to catalysis. The domain evidence therefore supports annotation as an enzyme and DNA sensor, rather than merely a DNA-binding adaptor.

5. Subcellular localization

Current consensus

Calling cGAS exclusively “cytosolic” is outdated. In mammalian cells, functional cGAS can occur in at least three operational pools:

1. Nucleus/chromatin: In many resting human and mouse cell types, the predominant pool is nuclear and tightly tethered to nucleosomes.
2. Plasma-membrane-associated cytosolic face: Binding to phosphoinositides can retain a pool at the membrane and limit inappropriate access to self-DNA.
3. Soluble cytosolic or damage-associated compartments: Following infection, mitochondrial damage, nuclear-envelope rupture, or release of aberrant DNA, cGAS can assemble on accessible extranuclear DNA.

A 2024 authoritative review reports that nuclear cGAS can constitute approximately 85–95% of total cGAS in some cell types. Reconstituted and cell-derived nucleosomes bind cGAS with dissociation constants of about 8.6 nM and 6.3 nM, respectively—over 100-fold tighter than naked DNA in the cited comparisons (Dvorkin et al., published April 2024; https://doi.org/10.1016/j.immuni.2024.02.019) (dvorkin2024newfrontiersin pages 3-4).

Prevention of self-DNA activation

Nuclear localization does not normally produce constitutive signaling because nucleosome tethering sequesters key cGAS DNA-binding and oligomerization surfaces. Conserved basic residues engage the acidic patch of the H2A–H2B histone dimer, sterically and allosterically preventing formation of the active cGAS–dsDNA assembly. Disrupting this tether can produce striking autoreactivity: mouse R241E generated about 300-fold more basal cGAMP than wild type, and human R255E generated over 100-fold more (Volkman et al., published December 2019; https://doi.org/10.7554/elife.47491) (volkman2019tightnucleartethering pages 11-12).

Accordingly, the best localization annotation for naked-mole-rat A0AAX6RS70 is intracellular; predicted nuclear/chromatin-associated and cytosolic/plasma-membrane-associated, with activation on aberrantly exposed dsDNA. Exact tissue, cell-type, and compartment distributions in H. glaber remain unmeasured.

6. Canonical signaling pathway

The inferred pathway is:

1. Mislocalized or pathogen-derived dsDNA binds cGAS.
2. Activated cGAS converts ATP and GTP into 2′3′-cGAMP.
3. cGAMP binds STING, an adaptor resident in the endoplasmic-reticulum membrane.
4. Activated STING traffics and creates signaling platforms that recruit TBK1 and related kinases.
5. TBK1 phosphorylates IRF3; parallel signaling activates NF-κB.
6. IRF3 and NF-κB induce type-I interferons, other antiviral genes, and inflammatory cytokines.

Depending on context, IRF7, IKKε, autophagy machinery, cell-death programs, and adaptive immune activation also contribute. cGAMP can leave the producing cell and enter neighboring cells through transporters, gap junctions, or packaged particles; it is therefore increasingly described as an immunotransmitter, not solely an intracellular second messenger (hertzog2020regulationandinhibition pages 3-4, civril2013structuralmechanismof pages 1-2, dvorkin2024newfrontiersin pages 1-3).

The canonical biological role is surveillance of intracellular DNA during viral and bacterial infection and detection of endogenous DNA damage. This can be protective, but persistent activation can cause interferonopathy, autoimmunity, sterile inflammation, or tissue damage.

7. Recent developments, 2023–2024

7.1 Nuclear cGAS is now central, not exceptional

Recent reviews emphasize that nuclear, nucleosome-tethered cGAS is often the dominant resting pool. Current research asks how subsets of nuclear cGAS become accessible during nuclear-envelope rupture, micronucleus formation, viral infection, senescence, or altered chromatin states. The field has therefore shifted from a simple “cytosolic receptor excluded from genomic DNA” model to a compartmentalized and actively restrained intracellular sensor model (Dvorkin et al., April 2024; https://doi.org/10.1016/j.immuni.2024.02.019; Zheng et al., September 2023; https://doi.org/10.3390/ijms241914738) (dvorkin2024newfrontiersin pages 9-11, dvorkin2024newfrontiersin pages 3-4, zheng2023howdoescgas pages 13-15).

7.2 DNA damage and micronuclei require more nuanced interpretation

Accumulation of cGAS on a micronucleus is not by itself proof of productive cGAMP–STING signaling. Recent work indicates that some micronuclei recruit cGAS during mitosis without subsequently activating STING. Thus, localization, enzymatic activation, and downstream pathway engagement must be measured separately. This is especially relevant when designing experiments for naked-mole-rat cells: microscopy alone would be insufficient to establish function.

7.3 Noncanonical nuclear functions

Recent literature associates chromatin-bound cGAS with DNA-damage responses, senescence-associated secretory phenotypes, DNA repair, replication, chromatin regulation, and cancer-cell plasticity. Some findings are contradictory—for example, cGAS-STING signaling can either restrict chromosomal instability or inhibit homology-directed repair—suggesting strong dependence on cell type, damage source, localization, and whether the effect requires STING (dvorkin2024newfrontiersin pages 9-11).

These noncanonical functions should not yet be incorporated into the core annotation of A0AAX6RS70. They are emerging mammalian functions, not directly demonstrated naked-mole-rat phenotypes.

8. Naked-mole-rat-specific interpretation

The search found literature discussing naked-mole-rat longevity, cancer resistance, genome annotation, immune-system peculiarities, and pathway-level cGAS–STING concepts, but not an experiment directly testing Mb21d1/cGAS A0AAX6RS70. Consequently:

• There is no verified naked-mole-rat kinetic constant, catalytic rate, DNA-length response curve, product measurement, structure, tissue-expression map, or subcellular localization for this accession.
• There is no retrieved Mb21d1 knockout/knockdown experiment in naked-mole-rat cells.
• Naked-mole-rat longevity or cancer resistance must not be attributed to this protein on current evidence.
• The “isoform X1” model may change as the naked-mole-rat genome and transcript annotation improve.

This caution is particularly important for non-model organisms, where assembly or annotation artifacts can yield incorrect exon structures or isoforms. The appropriate confidence statement is: orthology and domain architecture strongly support cGAS function, but the exact naked-mole-rat protein model and its species-specific regulation remain unvalidated.

9. Applications and translational relevance

At the mammalian pathway level, cGAS–STING is being exploited in several ways:

• Cancer immunotherapy: STING agonists and cGAMP-delivery systems aim to induce type-I IFN, antigen presentation, dendritic-cell activation, and T-cell recruitment in immunologically “cold” tumors.
• Vaccine adjuvants: cGAMP analogues and DNA/cGAS-activating formulations are being evaluated as innate immune adjuvants.
• Inflammatory and autoimmune disease: Active-site cGAS inhibitors, DNA-binding inhibitors, and STING inhibitors are being developed to suppress pathological self-DNA signaling.
• Infection: Pathway activation may enhance host defense, whereas inhibitors may limit immunopathology in settings where excessive inflammation is harmful.
• Biomarkers: Tumor cGAS abundance, cGAMP, phosphorylated STING/TBK1/IRF3, and interferon signatures are being evaluated as pharmacodynamic or response markers.

As of the 2024 literature, STING agonists had entered clinical trials, but no STING agonist had received clinical approval; delivery, systemic toxicity, species-specific STING pharmacology, tumor heterogeneity, and context-dependent protumor effects remained major obstacles. cGAS inhibitors were still primarily preclinical. These applications concern human or model-organism cGAS–STING and are not implementations of naked-mole-rat A0AAX6RS70 (dvorkin2024newfrontiersin pages 1-3, zheng2023howdoescgas pages 13-15).

10. Recommended experimental validation

A rigorous validation program for A0AAX6RS70 should include:

1. Transcript validation: Long-read RNA sequencing and 5′/3′ RACE across naked-mole-rat tissues to confirm the “isoform X1” exon structure.
2. Sequence analysis: Alignment against human, mouse, guinea-pig, and other hystricognath cGAS proteins, focusing on NTase acidic residues, nucleotide-binding loops, zinc-thumb, DNA-binding surfaces, and nucleosome-tethering residues.
3. Biochemistry: Purify the recombinant protein and quantify 2′3′-cGAMP by LC–MS using ATP, GTP, Mg²⁺, and dsDNA of systematically varied length and sequence.
4. Ligand controls: Compare dsDNA, ssDNA, dsRNA, RNA–DNA hybrids, nucleosomes, and mitochondrial DNA; binding alone should not be equated with catalysis.
5. Pathway reconstitution: Express naked-mole-rat cGAS with naked-mole-rat STING and measure cGAMP, STING trafficking, TBK1/IRF3 phosphorylation, IFN transcription, and NF-κB activation.
6. Localization: Use an antibody validated by Mb21d1 knockout, biochemical fractionation, and endogenous tagging to distinguish soluble cytosolic, membrane-associated, and chromatin-tethered pools.
7. Genetic causality: CRISPR disruption and catalytic-residue rescue in naked-mole-rat cells challenged with DNA viruses, transfected dsDNA, mitochondrial stress, or nuclear-envelope damage.

Final functional annotation

Mb21d1/cGAS A0AAX6RS70 is most likely an intracellular, dsDNA-activated Mab21-family nucleotidyltransferase that synthesizes 2′3′-cGAMP from ATP and GTP. Its product is predicted to activate ER-localized STING and downstream TBK1–IRF3 and NF-κB signaling, promoting type-I interferon and inflammatory gene expression. The protein is predicted to occupy regulated nuclear/chromatin-associated and cytosolic or plasma-membrane-associated pools. This annotation has strong mechanistic support from other mammalian cGAS orthologs, but direct functional and localization evidence for the specific naked-mole-rat accession remains absent.

References

1. (mann2016structuralandbiochemicala pages 25-28): CC Oliveira Mann. Structural and biochemical characterization of the mab21 family members and rig-i innate immune sensors. Unknown journal, 2016.

2. (civril2013structuralmechanismof pages 1-2): Filiz Civril, Tobias Deimling, Carina C. de Oliveira Mann, Andrea Ablasser, Manuela Moldt, Gregor Witte, Veit Hornung, and Karl-Peter Hopfner. Structural mechanism of cytosolic dna sensing by cgas. Nature, 498:332-337, May 2013. URL: https://doi.org/10.1038/nature12305, doi:10.1038/nature12305. This article has 1078 citations and is from a highest quality peer-reviewed journal.

3. (mann2016structuralandbiochemicala pages 71-72): CC Oliveira Mann. Structural and biochemical characterization of the mab21 family members and rig-i innate immune sensors. Unknown journal, 2016.

4. (hertzog2020regulationandinhibition pages 3-4): Jonny Hertzog and Jan Rehwinkel. Regulation and inhibition of the dna sensor cgas. EMBO reports, Nov 2020. URL: https://doi.org/10.15252/embr.202051345, doi:10.15252/embr.202051345. This article has 63 citations and is from a highest quality peer-reviewed journal.

5. (mann2016structuralandbiochemical pages 1-2): Carina C. de Oliveira Mann, Reiner Kiefersauer, Gregor Witte, and Karl-Peter Hopfner. Structural and biochemical characterization of the cell fate determining nucleotidyltransferase fold protein mab21l1. Scientific Reports, Jun 2016. URL: https://doi.org/10.1038/srep27498, doi:10.1038/srep27498. This article has 55 citations and is from a peer-reviewed journal.

6. (tao2017nonspecificdnabinding pages 3-4): Jianli Tao, Xiao-Wei Zhang, Jianshi Jin, Xiao-Xia Du, Tengfei Lian, Jing Yang, Xiang Zhou, Zhengfan Jiang, and Xiao-Dong Su. Nonspecific dna binding of cgas n terminus promotes cgas activation. May 2017. URL: https://doi.org/10.4049/jimmunol.1601909, doi:10.4049/jimmunol.1601909. This article has 93 citations.

7. (dvorkin2024newfrontiersin pages 1-3): Steve Dvorkin, Stephanie Cambier, Hannah E. Volkman, and Daniel B. Stetson. New frontiers in the cgas-sting intracellular dna-sensing pathway. Immunity, 57 4:718-730, Apr 2024. URL: https://doi.org/10.1016/j.immuni.2024.02.019, doi:10.1016/j.immuni.2024.02.019. This article has 382 citations and is from a highest quality peer-reviewed journal.

8. (civril2013structuralmechanismof pages 4-6): Filiz Civril, Tobias Deimling, Carina C. de Oliveira Mann, Andrea Ablasser, Manuela Moldt, Gregor Witte, Veit Hornung, and Karl-Peter Hopfner. Structural mechanism of cytosolic dna sensing by cgas. Nature, 498:332-337, May 2013. URL: https://doi.org/10.1038/nature12305, doi:10.1038/nature12305. This article has 1078 citations and is from a highest quality peer-reviewed journal.

9. (dvorkin2024newfrontiersin pages 3-4): Steve Dvorkin, Stephanie Cambier, Hannah E. Volkman, and Daniel B. Stetson. New frontiers in the cgas-sting intracellular dna-sensing pathway. Immunity, 57 4:718-730, Apr 2024. URL: https://doi.org/10.1016/j.immuni.2024.02.019, doi:10.1016/j.immuni.2024.02.019. This article has 382 citations and is from a highest quality peer-reviewed journal.

10. (zheng2023howdoescgas pages 13-15): Wangli Zheng, Nanhua Chen, François Meurens, Wanglong Zheng, and Jianzhong Zhu. How does cgas avoid sensing self-dna under normal physiological conditions? International Journal of Molecular Sciences, 24:14738, Sep 2023. URL: https://doi.org/10.3390/ijms241914738, doi:10.3390/ijms241914738. This article has 13 citations.

11. (volkman2019tightnucleartethering pages 11-12): Hannah E Volkman, Stephanie Cambier, Elizabeth E Gray, and Daniel B Stetson. Tight nuclear tethering of cgas is essential for preventing autoreactivity. eLife, Dec 2019. URL: https://doi.org/10.7554/elife.47491, doi:10.7554/elife.47491. This article has 358 citations and is from a domain leading peer-reviewed journal.

12. (dvorkin2024newfrontiersin pages 9-11): Steve Dvorkin, Stephanie Cambier, Hannah E. Volkman, and Daniel B. Stetson. New frontiers in the cgas-sting intracellular dna-sensing pathway. Immunity, 57 4:718-730, Apr 2024. URL: https://doi.org/10.1016/j.immuni.2024.02.019, doi:10.1016/j.immuni.2024.02.019. This article has 382 citations and is from a highest quality peer-reviewed journal.

13. (ramos2024theroleof pages 18-18): Anna Ramos, Nazih Bizri, Elizabeth Novak, Kevin Mollen, and Sidrah Khan. The role of cgas in epithelial dysregulation in inflammatory bowel disease and gastrointestinal malignancies. Frontiers in Pharmacology, Jul 2024. URL: https://doi.org/10.3389/fphar.2024.1409683, doi:10.3389/fphar.2024.1409683. This article has 7 citations.

Artifacts

• Edison artifact artifact-00

Citations

1. dvorkin2024newfrontiersin pages 3-4
2. volkman2019tightnucleartethering pages 11-12
3. dvorkin2024newfrontiersin pages 9-11
4. mann2016structuralandbiochemicala pages 25-28
5. civril2013structuralmechanismof pages 1-2
6. mann2016structuralandbiochemicala pages 71-72
7. hertzog2020regulationandinhibition pages 3-4
8. mann2016structuralandbiochemical pages 1-2
9. tao2017nonspecificdnabinding pages 3-4
10. dvorkin2024newfrontiersin pages 1-3
11. civril2013structuralmechanismof pages 4-6
12. zheng2023howdoescgas pages 13-15
13. ramos2024theroleof pages 18-18
14. https://doi.org/10.1038/nature12305
15. https://doi.org/10.1016/j.immuni.2024.02.019
16. https://doi.org/10.7554/elife.47491
17. https://doi.org/10.1016/j.immuni.2024.02.019;
18. https://doi.org/10.3390/ijms241914738
19. https://doi.org/10.1038/nature12305,
20. https://doi.org/10.15252/embr.202051345,
21. https://doi.org/10.1038/srep27498,
22. https://doi.org/10.4049/jimmunol.1601909,
23. https://doi.org/10.1016/j.immuni.2024.02.019,
24. https://doi.org/10.3390/ijms241914738,
25. https://doi.org/10.7554/elife.47491,
26. https://doi.org/10.3389/fphar.2024.1409683,